IL141218A0 - Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption
- Google Patents
Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption
Info
Publication number
IL141218A0
IL141218A0IL14121898AIL14121898AIL141218A0IL 141218 A0IL141218 A0IL 141218A0IL 14121898 AIL14121898 AIL 14121898AIL 14121898 AIL14121898 AIL 14121898AIL 141218 A0IL141218 A0IL 141218A0
Authority
IL
Israel
Prior art keywords
medicament
kits
mixtures
manufacture
pharmaceutically acceptable
Prior art date
Application number
IL14121898A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=27517420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141218(A0)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9717590.5Aexternal-prioritypatent/GB9717590D0/en
Priority claimed from GBGB9717850.3Aexternal-prioritypatent/GB9717850D0/en
Application filed by Merck & Co IncfiledCriticalMerck & Co Inc
Priority claimed from PCT/US1998/014796external-prioritypatent/WO1999004773A2/en
Publication of IL141218A0publicationCriticalpatent/IL141218A0/en
IL14121898A1997-07-221998-07-17Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption
IL141218A0
(en)
Pharmaceutical composition useful for inhibiting bone resorption in a human comprising alendronic acid or pharmaceutically acceptable salt thereof or a mixture thereof
Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption
A combination of a histamine h2 receptor blocker or a proton pump inhibitor and a bisphosphonate or pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament, for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any thereof, all for inhibiting bone resorption
Pharmaceutical composition useful for inhibiting bone resorption in a human comprising alendronic acid or pharmaceutically acceptable salt thereof or a mixture thereof
A combination of a histamine h2 receptor blocker or a proton pump inhibitor and a bisphosphonate or pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament, for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any thereof, all for inhibiting bone resorption
Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them
Use of ibandronic acid and pharmaceutical acceptable salts thereof for the manufacture of a medicament for treating or preventing disorders characterized by increased bone resorption
Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents
Amidinobenzylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and use of such compositions in the preparation of a medicament for the inhibition of thrombin
Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
Alendronic acid, pharmaceutically acceptable salts thereof or mixtures thereof, for use as a medicament or for use in the manufacture of a medicament, pharmaceutical compositions and kits comprising any of thereof, all for inhibiting bone resorption